ZHOU Yan,ZHANG Yi,LIANG Yan,JIANG Jun.Association of ERβ expression with the clinical pathologic indexes and prognostic biomarkers of breast cancer[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(11):1090-1092.
ZHOU Yan,ZHANG Yi,LIANG Yan,JIANG Jun.Association of ERβ expression with the clinical pathologic indexes and prognostic biomarkers of breast cancer[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(11):1090-1092.DOI:
Association of ERβ expression with the clinical pathologic indexes and prognostic biomarkers of breast cancer
Objective To study the association of ERβ expression with the expression of hormonal receptor and prognostic biomarkers. Methods The expressions of ERβ
ERα
PR
Ki-67
HER-2/neu and p53 were detected in tissue samples from 109 breast cancer patients by immunohistochemistry on tissue microarray slides. The histologic grade
tumor size and lymph node metastasis status of 109 cases of breast cancer were recorded and served as comparison indexes. Results ERβ was expressed in benign epithelium and stroma cells
and breast cancer cells in 59% breast cancer tissues of different histologic types. ERβ was coexpressed with ERα in 45% breast cancer tissues. ERβ expression was found a statistically significant association with HER-2/neu (P0.05) and p53 (P0.05). No statistically significant association was seen between ERβ expression and histologic grade
tumor size and lymph node metastasis. Conclusion ERβ may be an important prognostic marker and therapeutic target in breast cancer.
A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR+/HER2- early breast cancer patients
Immunosuppressive microenvironment of TGIF1-overexpressing gastric cancers and its clinical significance
Impact of molecular heterogeneity of NPM1 mutations on prognosis of acute myeloid leukemia: a clinical report of 86 cases
Association of 5-factor modified frailty index and controlling nutritional status score with overall survival in patients with unresectable hepatocellular carcinoma undergoing interventional therapy
Construction and validation of prediction model for cervical cancer recurrence based on systemic inflammation response index and clinicopathological parameters
Related Author
WANG Chengfang
ZHOU Yuqin
ZHANG Yanling
QI Xiaowei
ZHANG Yi
TONG Huyun
CHEN Xu
ZHANG Wenjie
Related Institution
Department of Breast and Thyroid Surgery, First Affiliated Hospital, Army Medical University (Third Military Medical University)
Department of Gastroenterology, Chongqing Hechuan District People’s Hospital
School of Medicine, Chongqing University
Chongqing Key Laboratory of Precision Prevention and Treatment for Digestive System Tumors, Department of Gastroenterology, Army Medical Center of PLA/Daping Hospital of Third Military Medical University
Department of Hematology, the First Hospital of Lanzhou University